Tachmed, expert developers of intuitive at-home digital diagnostic technology, has announced a new partnership with Doctor Now, a private GP service offering a wide range of independent primary care services.
Doctor Now will work with Tachmed to assist in the trials and roll-out of their products, influencing routes to market across the NHS and private primary care and hospital providers.
The insight gathered during these trials will play a vital role in the future deployment of the Tachmed device to consumers and other organisations.
Gary Robinson, chief executive officer at Doctor Now, will also join the Tachmed advisory board, providing clinical feedback on Tachmed products and services, as well as collaborating with Tachmed’s research and development team to refine its technology.
As an established 24 hours a day, 7 days a week GP service, Doctor Now offers patients and corporate clients a choice of face-to-face, telephone and online consultations and rapid referral into secondary care and allied health services. The introduction of the Tachmed device will significantly improve the efficiency of both diagnosis and subsequent treatment.
Gary Robinson, chief executive officer at Doctor Now said:
“I am delighted to have been invited to join the advisory board of Tachmed on behalf of Doctor Now and the leadership team. Seeking to disrupt the current pathology market with cloud-based, at-home testing technology. Tachmed’s progressive approach to healthcare will allow us to deliver test results at a fraction of the time and cost of traditional wet labs.
“In addition, point-of-care devices will provide a more efficient, fairer and faster service for patients and the wider health economy. I’m really excited to see how this technology will improve patient outcomes around the world over the coming years.”
Paul Christie, co-founder and chief executive officer at Tachmed said:
“There is a clear meeting of minds between Tachmed and Doctor Now, with both businesses determined to improve primary health services and deliver a digital-first operating model that’s fit for the 21st century. Gary will join a number of expert clinicians and scientists already working on the Tachmed advisory board, shaping our future product roadmap and the development of our technology.”
Tachmed has global stakeholder partnerships with leading universities, tech companies and supra-national organisations.
For more information visit: https://tachmed.com/